Schizophrenia

Showing NaN - NaN of 144

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Schizophrenia Trial in Garden Grove, Marlton (MK-8189, Placebo)

Active, not recruiting
  • Schizophrenia
  • Garden Grove, California
  • +2 more
Jan 31, 2023

Agitation,Psychomotor, Bipolar I Disorder, Bipolar II Disorder Trial in United States (BXCL501, Matching Placebo)

Recruiting
  • Agitation,Psychomotor
  • +5 more
  • Little Rock, Arkansas
  • +16 more
Jan 31, 2023

Schizophrenia Trial in Worldwide (BI 425809, Placebo)

Recruiting
  • Schizophrenia
  • Garden Grove, California
  • +102 more
Jan 27, 2023

Schizophrenia Trial in San Diego, Richardson (CVL-231 10 mg, Required CVL-231 30 mg, Placebo)

Recruiting
  • Schizophrenia
  • CVL-231 10 mg
  • +2 more
  • Little Rock, Arkansas
  • +15 more
Jan 27, 2023

Schizophrenia Trial in United States (SEP-363856)

Recruiting
  • Schizophrenia
  • Culver City, California
  • +14 more
Jan 26, 2023

Schizophrenia Trial in United States (Placebo, Valbenazine)

Recruiting
  • Schizophrenia
  • Phoenix, Arizona
  • +40 more
Jan 20, 2023

Cognitive Impairment Associated With Schizophrenia (CIAS), Cognitive Impairment, Schizophrenia Trial in Garden Grove (RL-007,

Recruiting
  • Cognitive Impairment Associated With Schizophrenia (CIAS)
  • +2 more
  • Garden Grove, California
    Collaborative Neuroscience Research
Jan 8, 2023

ERG Components in Schizophrenia and Bipolar Disorder Type I

Recruiting
  • Schizophrenia
  • Bipolar I Disorder
  • ERG assessment (RSPA)
  • Garden Grove, California
  • +19 more
Jan 12, 2023

Schizophrenia Trial in Worldwide (MK-8189, Risperidone, Placebo to MK-8189)

Recruiting
  • Schizophrenia
  • Bentonville, Arkansas
  • +92 more
Jan 5, 2023

Schizophrenia Trial (CVL-231 30 mg)

Enrolling by invitation
  • Schizophrenia
  • CVL-231 30 mg
  • Bentonville, Arkansas
  • +16 more
Dec 7, 2022

Schizophrenia Trial in Worldwide (BI 425809, Placebo)

Completed
  • Schizophrenia
  • BI 425809
  • Placebo
  • Little Rock, Arkansas
  • +50 more
Nov 7, 2022

Schizophrenia Trial in Worldwide (Placebo, AVP-786)

Recruiting
  • Schizophrenia
  • Little Rock, Arkansas
  • +81 more
Aug 23, 2022

Schizophrenia Trial in United States (CT-155 smartphone app)

Enrolling by invitation
  • Schizophrenia
  • CT-155 smartphone app
  • Culver City, California
  • +9 more
Aug 18, 2022

Schizophrenia Trial in United States (Xanomeline and Trospium Chloride Capsules, Placebo)

Recruiting
  • Schizophrenia
  • Xanomeline and Trospium Chloride Capsules
  • Placebo
  • Little Rock, Arkansas
  • +18 more
Aug 12, 2022

Schizophrenia Trial in Garden Grove, Gaithersburg, Marlton (Iloperidone)

Recruiting
  • Schizophrenia
  • Garden Grove, California
  • +2 more
Jun 1, 2022

Schizophrenia Trial in Worldwide (BI 409306, Placebo)

Terminated
  • Schizophrenia
  • BI 409306
  • Placebo
  • Phoenix, Arizona
  • +58 more
Apr 19, 2022

Schizophrenia Trial in United States (ASP4345, , risperidone)

Completed
  • Schizophrenia
  • Cerritos, California
  • +26 more
Apr 14, 2022

Schizophrenia Trial in Garden Grove, Marlton (SP-624, Placebo)

Completed
  • Schizophrenia
  • Garden Grove, California
  • +1 more
Apr 18, 2022

Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010 156 mg treatment group, deltoid, LY03010 156

Recruiting
  • Schizophrenia
  • +11 more
  • LY03010 156 mg treatment group, deltoid
  • +3 more
  • Little Rock, Arkansas
  • +8 more
Apr 11, 2022

Schizophrenia Trial in United States (Brilaroxazine, Placebo)

Recruiting
  • Schizophrenia
  • Phoenix, Arizona
  • +17 more
Apr 1, 2022

Schizophrenia Trial in Ukraine, United States (Risperidone ISM 75 mg, Risperidone ISM 100 mg)

Completed
  • Schizophrenia
  • Risperidone ISM 75 mg
  • Risperidone ISM 100 mg
  • Rogers, Arkansas
  • +23 more
Feb 24, 2022

Schizophrenia, Schizophreniform Disorder, Bipolar I Disorder Trial in Worldwide (ALKS 3831)

Active, not recruiting
  • Schizophrenia
  • +2 more
  • ALKS 3831
  • Little Rock, Arkansas
  • +85 more
Feb 10, 2022

Schizophrenia, Schizophreniform Disorders, Bipolar I Disorder Trial in Worldwide (ALKS 3831, Olanzapine)

Completed
  • Schizophrenia
  • +2 more
  • Little Rock, Arkansas
  • +56 more
Jan 5, 2022

Schizophrenia Trial in United States (Risperidone ISMĀ® 100 mg, Risperdal 4mg Tablet)

Completed
  • Schizophrenia
  • Risperidone ISMĀ® 100 mg
  • Risperdal 4mg Tablet
  • Garden Grove, California
  • +3 more
Dec 16, 2021

Schizophrenia Trial in United States (CTP-692, Placebo)

Completed
  • Schizophrenia
  • Little Rock, Arkansas
  • +23 more
Dec 13, 2021